中文 | English
Return
Total: 14 , 1/2
Show Home Prev Next End page: GO
Author:(Hiroyasu Sato)

1.Comparison between Risks Listed in the Risk Management Plan and the Product Labeling of the Drug Package Insert

Hiroyasu Sato ; Eimi Ohira ; Tomoka Murakami ; Yusuke Kanetaka ; Takahiro Murakami ; Hideaki Izumi ; Yoshihiro Hashimoto ; Hitoshi Komori

Japanese Journal of Drug Informatics 2016;17(4):205-208

2.Influence of Similarity of the Sheet Appearance in Multiple-Specification Drug on Taking Error

Hiroyasu Sato ; Yusuke Kanetaka ; Kohei Fujita ; Yuto Taniguchi ; Kiyomi Ishida ; Marino Ishio ; Hitoshi Komori

Japanese Journal of Drug Informatics 2016;18(3):186-191

3.Factors Influencing the Dispensing of One-Dose Package Medications to Elderly Outpatients

Hiroyasu Sato ; Sayumi Kadono ; Yusuke Kanetaka ; Shintaro Hirasawa ; Shizuna Namba ; Marino Ishio ; Kiyomi Ishida ; Hitoshi Komori

Japanese Journal of Social Pharmacy 2017;36(1):14-20

4.Survey of the Description of the Risk Minimization Activities in Pharmaceutical Risk Management Plans

Hiroyasu Sato ; Shintaro Hirasawa ; Sayumi Kadono ; Tomohiro Haruyama ; Kohei Fujita ; Yusuke Kanetaka ; Hiroshi Tamura ; Hitoshi Komori

Japanese Journal of Drug Informatics 2017;19(1):32-36

5.Influence of Sensual Similarity of Drug Name on Taking Error

Hiroyasu Sato ; Kohei Fujita ; Yuto Taniguchi ; Hiroko Yahata ; Tomohiro Haruyama ; Yoshihiro Hashimoto ; Shigeki Tanaka ; Hitoshi Komori

Japanese Journal of Drug Informatics 2012;14(1):14-20

6.Influence of Medicine Shelf Arrangement on Dispensing Error

Hiroyasu Sato ; Tomohiro Haruyama ; Namiko Ooi ; Yuto Taniguchi ; Kiyomi Ishida ; Hiroko Yahata ; Yoshihiro Hashimoto ; Hitoshi Komori

Japanese Journal of Drug Informatics 2014;16(2):63-69

7.ChatGPT (GPT-4) passed the Japanese National License Examination for Pharmacists in 2022, answering all items including those with diagrams: a descriptive study

Hiroyasu SATO ; Katsuhiko OGASAWARA

Journal of Educational Evaluation for Health Professions 2024;21(1):4-

8.ChatGPT (GPT-4) passed the Japanese National License Examination for Pharmacists in 2022, answering all items including those with diagrams: a descriptive study

Hiroyasu SATO ; Katsuhiko OGASAWARA

Journal of Educational Evaluation for Health Professions 2024;21(1):4-

9.ChatGPT (GPT-4) passed the Japanese National License Examination for Pharmacists in 2022, answering all items including those with diagrams: a descriptive study

Hiroyasu SATO ; Katsuhiko OGASAWARA

Journal of Educational Evaluation for Health Professions 2024;21(1):4-

10.ChatGPT (GPT-4) passed the Japanese National License Examination for Pharmacists in 2022, answering all items including those with diagrams: a descriptive study

Hiroyasu SATO ; Katsuhiko OGASAWARA

Journal of Educational Evaluation for Health Professions 2024;21(1):4-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 14 , 1/2 Show Home Prev Next End page: GO